Board Change • 5h
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Director Jean-Charles Dudek was the last director to join the board, commencing their role in 2025. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. 공시 • May 07
Reboost Blockchain Corp., Annual General Meeting, Jun 10, 2026 Reboost Blockchain Corp., Annual General Meeting, Jun 10, 2026. Location: 3 rue d heliopolis, paris France 공시 • Feb 17
Pyratzlabs signed a letter of intent to acquire Reboost Blockchain Corp. (ENXTPA:MLCOT) in a reverse merger transaction. Pyratzlabs signed a letter of intent to acquire Reboost Blockchain Corp. (ENXTPA:MLCOT) in a reverse merger transaction on February 15, 2026. The transaction is subject to both shareholder approval and regulatory clearance before it can be finalized. The transaction is expected to close in the first half of 2026. New Risk • Nov 09
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Negative equity (-€21k). Revenue is less than US$1m (€15k revenue, or US$18k). Market cap is less than US$10m (€2.00m market cap, or US$2.31m). Minor Risks Latest financial reports are more than 6 months old (reported December 2024 fiscal period end). New Risk • Jun 09
New major risk - Financial data availability The company's latest financial reports are more than a year old. Last reported fiscal period ended December 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2022 fiscal period end). Share price has been highly volatile over the past 3 months (29% average weekly change). Negative equity (-€82k). Revenue has declined by 100% over the past year. Revenue is less than US$1m (€1.0 revenue, or US$1.0). Market cap is less than US$10m (€268.1k market cap, or US$289.6k). New Risk • Dec 31
New major risk - Revenue and earnings growth Revenue has declined by 100% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Negative equity (-€82k). Revenue has declined by 100% over the past year. Shareholders have been substantially diluted in the past year (303% increase in shares outstanding). Revenue is less than US$1m (€1.0 revenue, or US$1.0). Market cap is less than US$10m (€67.0k market cap, or US$74.0k). Minor Risk Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). New Risk • Dec 25
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Negative equity (-€82k). Shareholders have been substantially diluted in the past year (303% increase in shares outstanding). Revenue is less than US$1m (€1.0 revenue, or US$1.0). Market cap is less than US$10m (€268.1k market cap, or US$295.3k). Minor Risk Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). 공시 • Jul 12
Gour Medical SA announced that it has received €0.135 million in funding Gour Medical SA announced a private placement of 3,375,000 shares at a price of €0.04 per share for gross proceeds of €135,000 on July 10, 2023. New Risk • Jul 09
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 303% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Negative equity (-€82k). Shareholders have been substantially diluted in the past year (303% increase in shares outstanding). Revenue is less than US$1m (€1.0 revenue, or US$1.0). Market cap is less than US$10m (€536.3k market cap, or US$588.0k). Board Change • Jun 19
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Director Gilles Avenard was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Apr 25
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Director Gilles Avenard was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Nov 21
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Director Gilles Avenard was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Oct 31
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Director Gilles Avenard was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Jul 07
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Director Gilles Avenard was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • May 12
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Director Gilles Avenard was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Director Gilles Avenard was the last director to join the board, commencing their role in 2019. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.